Population Pharmacokinetics of the BEACOPP Polychemotherapy Regimen in Hodgkin???s Lymphoma and its Effect on Myelotoxicity-Reference-Cited by-同舟云学术

Population Pharmacokinetics of the BEACOPP Polychemotherapy Regimen in Hodgkin???s Lymphoma and its Effect on Myelotoxicity

Published:2007 Issue:4 Volume:46 Page:319-333
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clinical Pharmacokinetics

Author:

Wilde Stefan,Jetter Alexander,Rietbrock Stephan,Kasel Dirk,Engert Andreas,Josting Andreas,Klimm Beate,Hempel Georg,Reif Stefanie,Jaehde Ulrich,Merkel Ute,Busse Dagmar,Schwab Matthias,Diehl Volker,Fuhr Uwe

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference55 articles.

1. BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease

2. Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease

3. Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease

4. BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.

5. Moderate Dose Escalation for Advanced Stage Hodgkin’s Disease Using the Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Scheme and Adjuvant Radiotherapy: A Study of the German Hodgkin’s Lymphoma Study Group

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetics of doxorubicin: A systematic review;Asia-Pacific Journal of Clinical Oncology;2022-04-12

2. Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells;Cancer Chemotherapy and Pharmacology;2022-02-12

3. Evaluation for pharmacokinetic exposure of cytotoxic anticancer drugs in elderly patients receiving (R-)CHOP therapy;Scientific Reports;2021-01-12

4. Cyclophosphamide dose adjustment based on body weight and albuminemia in elderly patients treated with R-mini-CHOP;Cancer Chemotherapy and Pharmacology;2019-01-28

5. Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction;British Journal of Pharmacology;2017-05-16